{"title":"481-P:慢性肾脏疾病增加糖尿病视网膜病变患者痴呆风险——一项基于韩国国家健康信息数据的研究","authors":"NA HYUN SONG, YEONSOO PARK, MIN KYONG MOON","doi":"10.2337/db25-481-p","DOIUrl":null,"url":null,"abstract":"Introduction and Objective: Diabetes mellitus (DM) and its complications are global health problem. Dementia, which also causes substantial morbidity and mortality among the elderly, has been shown to be associated with diabetic retinopathy (DR) and chronic kidney disease (CKD). However, the combined impact of these conditions on dementia risk remains unclear. This study aims to investigate the individual and combined effects of DR and CKD on dementia risk. Methods: Using the nationwide database of National Health Insurance Service in South Korea, 2,356,298 patients aged 40 years or older with diabetes who underwent routine health examination from 2015 to 2016 were included. The mean follow-up duration was 5.63 years. Dementia incidence was defined using International Classification of Diseases 10th revision codes (ICD-10). Cox proportional hazards analysis was used to calculate hazard ratios (HR) of dementia in patients with CKD or DR, adjusting for covariates such as age, sex, BMI, income, smoking, alcohol consumption, and comorbidities. Results: The incidence rate (IR) of dementia was increased in patients with CKD (HR 1.16, 95% CI: 1.15-1.18). Similarly, DR patients showed higher dementia risk compared to non-DR patients, with proliferative diabetic retinopathy (PDR) associated with higher HR of 1.26 (95% CI: 1.21-1.31) compared to 1.09 (95% CI 1.08-1.10) in non-PDR patients. Furthermore, CKD amplified dementia risk in DR patients. Compared to patients without CKD or DR, patients with CKD and PDR had an HR of 1.57 (95% CI 1.49-1.64), higher than the HR in PDR patients without CKD (HR 1.26, 95% CI 1.21-1.31). Subgroup analysis showed that younger patients (age 40-64 years) had higher HRs than older patients (≥65 years) within the same disease groups. Conclusion: This study suggests the synergistic effect of CKD in DR patients on dementia risk, emphasizing the need of early screening and integrated care for diabetes-related complications. Disclosure N. Song: None. Y. Park: None. M. Moon: None.","PeriodicalId":11376,"journal":{"name":"Diabetes","volume":"42 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"481-P: Chronic Kidney Disease Amplifies Dementia Risk in Patients with Diabetic Retinopathy—A Korean National Health Information Data-Based Study\",\"authors\":\"NA HYUN SONG, YEONSOO PARK, MIN KYONG MOON\",\"doi\":\"10.2337/db25-481-p\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction and Objective: Diabetes mellitus (DM) and its complications are global health problem. Dementia, which also causes substantial morbidity and mortality among the elderly, has been shown to be associated with diabetic retinopathy (DR) and chronic kidney disease (CKD). However, the combined impact of these conditions on dementia risk remains unclear. This study aims to investigate the individual and combined effects of DR and CKD on dementia risk. Methods: Using the nationwide database of National Health Insurance Service in South Korea, 2,356,298 patients aged 40 years or older with diabetes who underwent routine health examination from 2015 to 2016 were included. The mean follow-up duration was 5.63 years. Dementia incidence was defined using International Classification of Diseases 10th revision codes (ICD-10). Cox proportional hazards analysis was used to calculate hazard ratios (HR) of dementia in patients with CKD or DR, adjusting for covariates such as age, sex, BMI, income, smoking, alcohol consumption, and comorbidities. Results: The incidence rate (IR) of dementia was increased in patients with CKD (HR 1.16, 95% CI: 1.15-1.18). Similarly, DR patients showed higher dementia risk compared to non-DR patients, with proliferative diabetic retinopathy (PDR) associated with higher HR of 1.26 (95% CI: 1.21-1.31) compared to 1.09 (95% CI 1.08-1.10) in non-PDR patients. Furthermore, CKD amplified dementia risk in DR patients. Compared to patients without CKD or DR, patients with CKD and PDR had an HR of 1.57 (95% CI 1.49-1.64), higher than the HR in PDR patients without CKD (HR 1.26, 95% CI 1.21-1.31). Subgroup analysis showed that younger patients (age 40-64 years) had higher HRs than older patients (≥65 years) within the same disease groups. Conclusion: This study suggests the synergistic effect of CKD in DR patients on dementia risk, emphasizing the need of early screening and integrated care for diabetes-related complications. Disclosure N. Song: None. Y. Park: None. M. Moon: None.\",\"PeriodicalId\":11376,\"journal\":{\"name\":\"Diabetes\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2337/db25-481-p\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2337/db25-481-p","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
481-P: Chronic Kidney Disease Amplifies Dementia Risk in Patients with Diabetic Retinopathy—A Korean National Health Information Data-Based Study
Introduction and Objective: Diabetes mellitus (DM) and its complications are global health problem. Dementia, which also causes substantial morbidity and mortality among the elderly, has been shown to be associated with diabetic retinopathy (DR) and chronic kidney disease (CKD). However, the combined impact of these conditions on dementia risk remains unclear. This study aims to investigate the individual and combined effects of DR and CKD on dementia risk. Methods: Using the nationwide database of National Health Insurance Service in South Korea, 2,356,298 patients aged 40 years or older with diabetes who underwent routine health examination from 2015 to 2016 were included. The mean follow-up duration was 5.63 years. Dementia incidence was defined using International Classification of Diseases 10th revision codes (ICD-10). Cox proportional hazards analysis was used to calculate hazard ratios (HR) of dementia in patients with CKD or DR, adjusting for covariates such as age, sex, BMI, income, smoking, alcohol consumption, and comorbidities. Results: The incidence rate (IR) of dementia was increased in patients with CKD (HR 1.16, 95% CI: 1.15-1.18). Similarly, DR patients showed higher dementia risk compared to non-DR patients, with proliferative diabetic retinopathy (PDR) associated with higher HR of 1.26 (95% CI: 1.21-1.31) compared to 1.09 (95% CI 1.08-1.10) in non-PDR patients. Furthermore, CKD amplified dementia risk in DR patients. Compared to patients without CKD or DR, patients with CKD and PDR had an HR of 1.57 (95% CI 1.49-1.64), higher than the HR in PDR patients without CKD (HR 1.26, 95% CI 1.21-1.31). Subgroup analysis showed that younger patients (age 40-64 years) had higher HRs than older patients (≥65 years) within the same disease groups. Conclusion: This study suggests the synergistic effect of CKD in DR patients on dementia risk, emphasizing the need of early screening and integrated care for diabetes-related complications. Disclosure N. Song: None. Y. Park: None. M. Moon: None.
期刊介绍:
Diabetes is a scientific journal that publishes original research exploring the physiological and pathophysiological aspects of diabetes mellitus. We encourage submissions of manuscripts pertaining to laboratory, animal, or human research, covering a wide range of topics. Our primary focus is on investigative reports investigating various aspects such as the development and progression of diabetes, along with its associated complications. We also welcome studies delving into normal and pathological pancreatic islet function and intermediary metabolism, as well as exploring the mechanisms of drug and hormone action from a pharmacological perspective. Additionally, we encourage submissions that delve into the biochemical and molecular aspects of both normal and abnormal biological processes.
However, it is important to note that we do not publish studies relating to diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus. Our aim is to provide a platform for research that contributes to advancing our understanding of the underlying mechanisms and processes of diabetes.